Amgen Deutschland

Amgen Deutschland company information, Employees & Contact Information

Amgen wurde 1980 gegründet und ist heute ein global führendes unabhängiges Biotechnologie-Unternehmen, das mit rund 28.000 Mitarbeitenden in fast 100 Ländern vertreten ist. Als Pionier der Biotechnologie verfügen wir bei Amgen über vier Jahrzehnte Erfahrung in der Erforschung, Entwicklung und Produktion von innovativen Humantherapeutika. Wir fokussieren uns auf Krankheiten, für die es nur wenige oder keine Therapiemöglichkeiten gibt. Weltweit profitieren jährlich Millionen von Patientinnen und Patienten mit schweren Erkrankungen von unseren Therapien. Unsere Arzneimittel kommen in der Nephrologie, Kardiologie, Hämatologie, Onkologie, Knochengesundheit, bei chronisch-entzündlichen und seltenen Erkrankungen zum Einsatz. Neben Originalpräparaten beinhaltet unser Portfolio auch Biosimilars. In Deutschland arbeiten wir an zwei Standorten mit rund 680 Mitarbeitenden (Stand: Januar 2025) jeden Tag daran, Patientinnen und Patienten zu helfen: Die Amgen GmbH in München wurde 1989 als Vertriebsgesellschaft gegründet. Der Fokus der rund 500 Mitarbeitenden liegt auf der klinischen Forschung, der Zulassung und dem Vertrieb von Arzneimitteln. Die Amgen Research (Munich) GmbH ist Amgens größter Forschungsstandort außerhalb der USA mit einer Spezialisierung auf innovative Krebstherapien. Etwa 180 Mitarbeitende (Stand: Dezember 2023) arbeiten an der Erforschung und Entwicklung der BiTE® („Bispecific T-cell Engager“) Moleküle. Mehr zu Amgen in Deutschland auf amgen.de. Informationen für Bewerber: Besuchen Sie unser Bewerberportal mit unseren aktuellen Stellenangeboten bei der Amgen GmbH (https://careers.amgen.com/locations/germany/) und der Amgen Research (Munich) GmbH (https://careers.amgen.com/locations/germany-munich/). Unsere Social Media Guidelines: https://www.amgen.de/social-media-community-guidelines/ Bitte beachten Sie auch unser Impressum und unsere Datenschutzerklärung: https://www.amgen.de/impressum/ und https://www.amgen.de/datenschutz/
Looking for a particular Amgen Deutschland employee's phone or email?

Amgen Deutschland Questions

News

Championing Change: Amgen’s Commitment to Blood Cancer Care in Hispanic Communities - Amgen

Championing Change: Amgen’s Commitment to Blood Cancer Care in Hispanic Communities Amgen

US Bancorp DE Has $198.15 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat

US Bancorp DE Has $198.15 Million Stock Holdings in Amgen Inc. $AMGN MarketBeat

From Service to Science: Amgen Scholar’s Journey Highlights Howard University’s Expanding Research Pipeline - The Dig at Howard University

From Service to Science: Amgen Scholar’s Journey Highlights Howard University’s Expanding Research Pipeline The Dig at Howard University

William Blair Reiterates a Buy on Amgen Inc (AMGN) - Yahoo Finance

William Blair Reiterates a Buy on Amgen Inc (AMGN) Yahoo Finance

Amgen Announces $2.38 Per Share Dividend Payout: Key Dates and Details Revealed - Stock Titan

Amgen Announces $2.38 Per Share Dividend Payout: Key Dates and Details Revealed Stock Titan

Here’s the prize money breakdown for each golfer at the 2025 Amgen Irish Open - Golf Digest Middle East

Here’s the prize money breakdown for each golfer at the 2025 Amgen Irish Open Golf Digest Middle East

With recent launches and more to come, Amgen's biosimilar business is trending up - Fierce Pharma

With recent launches and more to come, Amgen's biosimilar business is trending up Fierce Pharma

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY - PR Newswire

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY PR Newswire

Royalty Pharma plc (RPRX) Boosts Growth with $885M Amgen Imdelltra Royalty Deal - Yahoo Finance

Royalty Pharma plc (RPRX) Boosts Growth with $885M Amgen Imdelltra Royalty Deal Yahoo Finance

750 New Jobs: Amgen's $650M Puerto Rico Plant Expansion Boosts U.S. Biotech Manufacturing Hub - Stock Titan

750 New Jobs: Amgen's $650M Puerto Rico Plant Expansion Boosts U.S. Biotech Manufacturing Hub Stock Titan

The top 10 drugs losing US exclusivity in 2025 - Fierce Pharma

The top 10 drugs losing US exclusivity in 2025 Fierce Pharma

Amgen Can't Ditch Regeneron's Bundling Antitrust Suit - Law360

Amgen Can't Ditch Regeneron's Bundling Antitrust Suit Law360

Drugmaker Amgen to invest $200 million in India site, CEO says - Reuters

Drugmaker Amgen to invest $200 million in India site, CEO says Reuters

Amgen Sets Q2 2025 Earnings Call: CEO Bradway to Present Financial Results August 5 - Stock Titan

Amgen Sets Q2 2025 Earnings Call: CEO Bradway to Present Financial Results August 5 Stock Titan

Generative Biology: Designing Biologic Medicines with Greater Speed and Success - Amgen

Generative Biology: Designing Biologic Medicines with Greater Speed and Success Amgen

Mission and Values - Amgen

Mission and Values Amgen

Amgen Sets Q1 2025 Earnings Release: CEO Bradway to Lead May 1 Investor Call - Stock Titan

Amgen Sets Q1 2025 Earnings Release: CEO Bradway to Lead May 1 Investor Call Stock Titan

Access to Healthcare - Amgen

Access to Healthcare Amgen

$2.8B Peak Sales Potential: Royalty Pharma Acquires Rights to Breakthrough Lung Cancer Drug Imdelltra - Stock Titan

$2.8B Peak Sales Potential: Royalty Pharma Acquires Rights to Breakthrough Lung Cancer Drug Imdelltra Stock Titan

Amgen Launches The ENBREL Mini™ Single-Dose Prefilled Cartridge With AutoTouch™ Reusable Autoinjector That Is Ergonomically Designed For Patients - Amgen

Amgen Launches The ENBREL Mini™ Single-Dose Prefilled Cartridge With AutoTouch™ Reusable Autoinjector That Is Ergonomically Designed For Patients Amgen

New barriers to pharma deals: FTC challenges Amgen / Horizon merger without alleging product overlaps - Norton Rose Fulbright

New barriers to pharma deals: FTC challenges Amgen / Horizon merger without alleging product overlaps Norton Rose Fulbright

Deploying multi-physics simulations for biopharma process development on AWS - Amazon Web Services

Deploying multi-physics simulations for biopharma process development on AWS Amazon Web Services

From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy - ACS Publications

From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy ACS Publications

Amgen's Humira biosimilar Amjevita hits the market with 2 different list prices - Fierce Pharma

Amgen's Humira biosimilar Amjevita hits the market with 2 different list prices Fierce Pharma

Inebilizumab for Treatment of IgG4-Related Disease - The New England Journal of Medicine

Inebilizumab for Treatment of IgG4-Related Disease The New England Journal of Medicine

$600M Science Innovation Hub: Amgen's Massive R&D Investment to Create Hundreds of US Biotech Jobs - Stock Titan

$600M Science Innovation Hub: Amgen's Massive R&D Investment to Create Hundreds of US Biotech Jobs Stock Titan

At Amgen, Cross-Functional Teams Collaborate to Create Groundbreaking Therapies and Digital Health Tools - WIRED

At Amgen, Cross-Functional Teams Collaborate to Create Groundbreaking Therapies and Digital Health Tools WIRED

Exclusive: Amgen's Global Marketing Chief to Share Strategic Insights at RBC Healthcare Conference - Stock Titan

Exclusive: Amgen's Global Marketing Chief to Share Strategic Insights at RBC Healthcare Conference Stock Titan

Amgen Tour of California Spectating Tips from Pro Cyclists - Visit California

Amgen Tour of California Spectating Tips from Pro Cyclists Visit California

Amgen Completes $27.8B Acquisition of Horizon Therapeutics - Powder & Bulk Solids

Amgen Completes $27.8B Acquisition of Horizon Therapeutics Powder & Bulk Solids

Amgen Tour of California on ‘Hiatus’ for 2020 Season - Bicycling

Amgen Tour of California on ‘Hiatus’ for 2020 Season Bicycling

Sign of the times? US stocks up on Amgen's radiation sickness drug Nplate - Fierce Pharma

Sign of the times? US stocks up on Amgen's radiation sickness drug Nplate Fierce Pharma

Peter Sagan Wins Opening Stage Of Amgen Tour Of California - capradio.org

Peter Sagan Wins Opening Stage Of Amgen Tour Of California capradio.org

Major Clinical Trial Tech Partnership: Veeva and Amgen Join Forces to Revolutionize Drug Development - Stock Titan

Major Clinical Trial Tech Partnership: Veeva and Amgen Join Forces to Revolutionize Drug Development Stock Titan

Amgen Tour of California announces television schedule - Outside Magazine

Amgen Tour of California announces television schedule Outside Magazine

No Amgen Tour Of California Race In 2020 - capradio.org

No Amgen Tour Of California Race In 2020 capradio.org

Raise standards for preclinical cancer research - Nature

Raise standards for preclinical cancer research Nature

Amgen Tour of California draws top names of cycling - Los Angeles Daily News

Amgen Tour of California draws top names of cycling Los Angeles Daily News

Meet your Amgen Tour race leader, Latvian Toms Skujins - Outside Magazine

Meet your Amgen Tour race leader, Latvian Toms Skujins Outside Magazine

Genesis Championship: How to watch - europeantour.com

Genesis Championship: How to watch europeantour.com

Amgen Tour of California Route Announced - Cycling West

Amgen Tour of California Route Announced Cycling West

Leading Biotech Amgen's Chief Medical Officer to Share Company Updates at Wells Fargo Conference - Stock Titan

Leading Biotech Amgen's Chief Medical Officer to Share Company Updates at Wells Fargo Conference Stock Titan

Amgen Tour of California: Stage 5 sees cyclists breeze through Santa Barbara County - Lompoc Record

Amgen Tour of California: Stage 5 sees cyclists breeze through Santa Barbara County Lompoc Record

How Much Did Rory McIlroy Win At The Amgen Irish Open? - Golf Monthly

How Much Did Rory McIlroy Win At The Amgen Irish Open? Golf Monthly

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - The New England Journal of Medicine

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease The New England Journal of Medicine

Chris Horner says diet his biggest concern heading into Tour de France - Outside Magazine

Chris Horner says diet his biggest concern heading into Tour de France Outside Magazine

After the gold rush: The rise and fall of the Tour of California - Cyclingnews

After the gold rush: The rise and fall of the Tour of California Cyclingnews

Route Details Announced for Amgen Tour of California - Road Bike Action

Route Details Announced for Amgen Tour of California Road Bike Action

2014 Amgen Tour of California route revealed - Cyclingnews

2014 Amgen Tour of California route revealed Cyclingnews

Amgen’s cholesterol drug patent revoked in UPC first - Pinsent Masons

Amgen’s cholesterol drug patent revoked in UPC first Pinsent Masons

Tour of California 2017 - Cyclingnews

Tour of California 2017 Cyclingnews

Amgen Tour of California: Exploring the route possibilities - Cyclingnews

Amgen Tour of California: Exploring the route possibilities Cyclingnews

Amgen Tour of California: A climber's eye view - Cyclingnews

Amgen Tour of California: A climber's eye view Cyclingnews

Amgen Time Trial a Tour de Force as Racers Roll Through Solvang - Noozhawk

Amgen Time Trial a Tour de Force as Racers Roll Through Solvang Noozhawk

Tour of California 2019 route guide - Cycling Weekly

Tour of California 2019 route guide Cycling Weekly

Armstrong's fraud paralleled EPO-makers' feud - Cyclingnews

Armstrong's fraud paralleled EPO-makers' feud Cyclingnews

Top Amgen Deutschland Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant